A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
Clinical trial NCT02956122 · TERMINATED
Trial details
- NCT number
- NCT02956122
- Sponsor
- Baxalta now part of Shire
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-26
- Primary completion
- 2018-05-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.